Tarsus Pharmaceuticals (TARS) Announces Board Transition Plans

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Tarsus Pharmaceuticals (TARS) Announces Board Transition Plans

Tarsus Announces Transition Plans for Board of Directors

October 11, 2022 8:30 AM EDT

Co-founder and Chairman Michael Ackermann plans to transition off Board of Directors

Wendy Yarno will become Lead Independent Director and CEO Bobak Azamian will become Chairman upon Dr. Ackermanns expected transition

IRVINE, Calif., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to address patient needs, starting with eye care, through the application of proven science and new technology, today announced several expected upcoming transitions to its Board of Directors by year-end. Tarsus Co-Founder and Chairman, Michael Ackermann,... More